M. Daniely et al., COMPARATIVE GENOMIC HYBRIDIZATION ANALYSIS OF NONFUNCTIONING PITUITARY-TUMORS, The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1801-1805
Clinically nonfunctioning pituitary adenomas constitute about one thir
d of pituitary neoplasms and are considered monoclonal tumors. The mol
ecular mechanisms of tumorigenesis in these neoplasms are poorly under
stood, as evidenced by the paucity of reported somatic genetic alterat
ions. Furthermore, the somatic mutations detected to date were primari
ly ascribed to candidate genes or chromosomal regions: gsp, ras, p53 m
utations, and allelic losses of 11q and 13q. To gain insight into whic
h chromosomal regions bear genes involved in nonfunctioning pituitary
tumorigenesis, we examined 23 such tumors by comparative genomic hybri
dization. Four tumors showed no genetic abnormality, and the rest (17
of 23, 74%) exhibited at least one chromosomal region of abnormality.
Gains and losses affected all chromosomes (except for chromosome 14).
Notably, 8 of 23 tumors (34.7%) displayed sex chromosome and chromosom
e 18 aberrations (amplifications or deletions). Nonrandom DNA amplific
ation of subchromosomal regions on 4q, 5q (5q13-->5q23), 9p (9p21-->9p
ter), 13q (13q21-->13q32), and 17q were detected in 10-30% of the tumo
rs. Noteworthy, no tumor displayed deletion of 11q, the MEN1 gene locu
s. These findings suggest that genes localized to previously undescrib
ed chromosomal regions play a role in the tumorigenesis of nonfunction
ing, pituitary adenomas.